Oarsman Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $823K | Buy |
2,339
+4
| +0.2% | +$1.43K | 0.1% | 102 |
|
|
2025
Q4 | $764K | Sell |
2,335
-149
| -6% | -$47.3K | 0.1% | 111 |
|
|
2025
Q3 | $701K | Sell |
2,484
-164
| -6% | -$47.6K | 0.1% | 114 |
|
|
2025
Q2 | $739K | Buy |
2,648
+106
| +4% | +$30K | 0.12% | 113 |
|
|
2025
Q1 | $792K | Sell |
2,542
-67
| -3% | -$19.8K | 0.14% | 109 |
|
|
2024
Q4 | $680K | Sell |
2,609
-202
| -7% | -$59.9K | 0.12% | 115 |
|
|
2024
Q3 | $906K | Buy |
2,811
+10
| +0.4% | +$3.27K | 0.17% | 99 |
|
|
2024
Q2 | $875K | Sell |
2,801
-49
| -2% | -$14.4K | 0.19% | 94 |
|
|
2024
Q1 | $810K | Sell |
2,850
-1,160
| -29% | -$339K | 0.19% | 98 |
|
|
2023
Q4 | $1.15M | Sell |
4,010
-61
| -1% | -$16.6K | 0.31% | 79 |
|
|
2023
Q3 | $1.09M | Sell |
4,071
-269
| -6% | -$67.1K | 0.46% | 58 |
|
|
2023
Q2 | $964K | Hold |
4,340
| – | – | 0.42% | 67 |
|
|
2023
Q1 | $1.05M | Buy |
4,340
+712
| +20% | +$175K | 0.49% | 56 |
|
|
2022
Q4 | $953K | Sell |
3,628
-145
| -4% | -$38.9K | 0.49% | 59 |
|
|
2022
Q3 | $850K | Sell |
3,773
-190
| -5% | -$46.1K | 0.46% | 65 |
|
|
2022
Q2 | $964K | Sell |
3,963
-535
| -12% | -$131K | 0.48% | 65 |
|
|
2022
Q1 | $1.09M | Sell |
4,498
-95
| -2% | -$21.8K | 0.42% | 74 |
|
|
2021
Q4 | $1.03M | Sell |
4,593
-580
| -11% | -$122K | 0.41% | 78 |
|
|
2021
Q3 | $1.1M | Sell |
5,173
-50
| -1% | -$11.5K | 0.45% | 75 |
|
|
2021
Q2 | $1.27M | Sell |
5,223
-60
| -1% | -$14.8K | 0.51% | 67 |
|
|
2021
Q1 | $1.31M | Sell |
5,283
-593
| -10% | -$141K | 0.57% | 60 |
|
|
2020
Q4 | $1.35M | Sell |
5,876
-366
| -6% | -$84.4K | 0.52% | 60 |
|
|
2020
Q3 | $1.59M | Sell |
6,242
-223
| -3% | -$55.2K | 0.71% | 46 |
|
|
2020
Q2 | $1.52M | Buy |
6,465
+3,596
| +125% | +$820K | 0.75% | 41 |
|
|
2020
Q1 | $582K | Sell |
2,869
-3,838
| -57% | -$838K | 0.54% | 57 |
|
|
2019
Q4 | $1.62M | Sell |
6,707
-160
| -2% | -$35.3K | 0.74% | 44 |
|
|
2019
Q3 | $1.33M | Sell |
6,867
-193
| -3% | -$37K | 0.63% | 52 |
|
|
2019
Q2 | $1.3M | Buy |
7,060
+60
| +0.9% | +$10.7K | 0.59% | 58 |
|
|
2019
Q1 | $1.33M | Buy |
7,000
+76
| +1% | +$14.5K | 0.63% | 56 |
|
|
2018
Q4 | $1.35M | Buy |
6,924
+281
| +4% | +$54.8K | 0.69% | 50 |
|
|
2018
Q3 | $1.38M | Sell |
6,643
-155
| -2% | -$30.5K | 0.55% | 62 |
|
|
2018
Q2 | $1.25M | Buy |
6,798
+55
| +0.8% | +$9.73K | 0.57% | 61 |
|
|
2018
Q1 | $1.15M | Sell |
6,743
-40
| -0.6% | -$7.34K | 0.52% | 66 |
|
|
2017
Q4 | $1.18M | Sell |
6,783
-115
| -2% | -$20.4K | 0.51% | 65 |
|
|
2017
Q3 | $1.29M | Sell |
6,898
-60
| -0.9% | -$10.6K | 0.54% | 62 |
|
|
2017
Q2 | $1.2M | Sell |
6,958
-280
| -4% | -$45.5K | 0.55% | 62 |
|
|
2017
Q1 | $1.19M | Buy |
7,238
+1,180
| +19% | +$196K | 0.55% | 61 |
|
|
2016
Q4 | $886K | Sell |
6,058
-1,355
| -18% | -$204K | 0.57% | 58 |
|
|
2016
Q3 | $1.24M | Sell |
7,413
-20
| -0.3% | -$3.38K | 0.63% | 54 |
|
|
2016
Q2 | $1.13M | Sell |
7,433
-40
| -0.5% | -$6.22K | 0.59% | 60 |
|
|
2016
Q1 | $1.12M | Sell |
7,473
-105
| -1% | -$15.6K | 0.6% | 60 |
|
|
2015
Q4 | $1.23M | Sell |
7,578
-90
| -1% | -$14.1K | 0.69% | 52 |
|
|
2015
Q3 | $1.06M | Sell |
7,668
-5
| -0.1% | -$788 | 0.63% | 59 |
|
|
2015
Q2 | $1.18M | Buy |
7,673
+40
| +0.5% | +$6.41K | 0.8% | 42 |
|
|
2015
Q1 | $1.22M | Sell |
7,633
-195
| -2% | -$30.7K | 0.84% | 39 |
|
|
2014
Q4 | $1.25M | Sell |
7,828
-130
| -2% | -$20.3K | 0.9% | 36 |
|
|
2014
Q3 | $1.12M | Sell |
7,958
-185
| -2% | -$24.2K | 0.82% | 41 |
|
|
2014
Q2 | $964K | Sell |
8,143
-150
| -2% | -$17.4K | 0.7% | 49 |
|
|
2014
Q1 | $1.02M | Buy |
8,293
+275
| +3% | +$33.4K | 0.79% | 45 |
|
|
2013
Q4 | $915K | Buy |
8,018
+1,630
| +26% | +$185K | 0.73% | 47 |
|
|
2013
Q3 | $715K | Buy |
6,388
+170
| +3% | +$18.4K | 0.62% | 59 |
|
|
2013
Q2 | $613K | Buy |
+6,218
| New | +$645K | 0.58% | 65 |
|
Other funds holding AMGN
VCM
VPM
Oarsman Capital's AMGN Position: Q1 2026 in Review
Oarsman Capital increased its Amgen (AMGN) stake by 0.17% in Q1 2026, buying an estimated $1.43K and bringing the position to 2,339 shares worth $823K. The position accounts for 0.1% of the portfolio, ranked #102.
Oarsman Capital first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.62M in Q4 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Oarsman Capital held 2,339 shares of Amgen worth $823K as of Q1 2026.
- Oarsman Capital bought 4 Amgen shares in Q1 2026, an estimated $1.43K.
- Amgen made up 0.1% of Oarsman Capital's portfolio in Q1 2026, its #102 holding.
- Oarsman Capital first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Oarsman Capital's Amgen position peaked at $1.62M in Q4 2019.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.